![](/img/cover-not-exists.png)
Effective targeting of primary human acute myeloid leukemia using anti-CD123 chimeric antigen receptor engineered T cells
Gill, S., Tasian, S.K., Scholler, J., Porter, D.L., Carroll, M.P., Grupp, S.A., June, C., Kalos, M.Volume:
15
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2013.01.047
Date:
April, 2013
File:
PDF, 152 KB
english, 2013